Home › Funds › Deer Management Co. LLC › KYMR
Deer Management Co. LLC position in KYMR
KYMERA THERAPEUTICS INC · Health Care
Deer Management Co. LLC reported holding 125,895 shares of KYMR (KYMERA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$14.4M, representing 1.78% of its reported portfolio and ranking #6 among its reported holdings. Deer Management Co. LLC has disclosed KYMR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Deer Management Co. LLC's KYMR position evolved
Deer Management Co. LLC first disclosed a stake in KYMR in Q3 2023 at 615,895 shares (US$8.6M). The position peaked in Q3 2024 at 415,895 shares, worth US$19.7M. Across 12 filings, Deer Management Co. LLC increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 125,895 shares valued at US$14.4M. Notable position changes include a 32% trim in Q1 2024 (shares fell 26% over the following quarter), a 29% trim in Q4 2025 (shares rose 7% over the following quarter), a 45% trim in Q1 2026 (shares rose 38% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 615.89K | $8.56M | New |
| Q4 2023 | 615.89K | $15.68M | Hold |
| Q1 2024 | 415.89K | $16.72M | Reduce |
| Q2 2024 | 415.89K | $12.41M | Hold |
| Q3 2024 | 415.89K | $19.68M | Hold |
| Q4 2024 | 415.89K | $16.73M | Hold |
| Q1 2025 | 415.89K | $11.38M | Hold |
| Q2 2025 | 325.89K | $14.22M | Reduce |
| Q3 2025 | 325.89K | $18.45M | Hold |
| Q4 2025 | 230.81K | $17.96M | Reduce |
| Q1 2026 | 125.89K | $10.49M | Reduce |
| Q2 2026 | 125.89K | $14.44M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KYMR and 13F data
KYMR (KYMERA THERAPEUTICS INC) is a Health Care company. 58 other funds we track also report a position in KYMR — the largest reported positions include BAKER BROS. ADVISORS LP (US$992.7M), Avoro Capital Advisors LLC (US$857.1M), T. Rowe Price Investment Management, Inc. (US$717.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KYMR
- BAKER BROS. ADVISORS LP 8.66M sh · $992.73M · Q2 2026
- Avoro Capital Advisors LLC 7.47M sh · $857.13M · Q2 2026
- T. Rowe Price Investment Management, Inc. 6.26M sh · $717.52M · Q2 2026
- BVF INC/IL 3.87M sh · $444.01M · Q2 2026
- Siren, L.L.C. 2.94M sh · $336.65M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 2.85M sh · $326.53M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 919.23K sh · $105.41M · Q2 2026
- Merck & Co., Inc. 772.16K sh · $88.54M · Q2 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 740.87K sh · $84.96M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 504.21K sh · $57.81M · Q2 2026
- Rock Springs Capital Management LP 453.16K sh · $51.96M · Q2 2026
- Boxer Capital Management, LLC 429.10K sh · $49.20M · Q2 2026
More on Deer Management Co. LLC
FAQ
How long has Deer Management Co. LLC held KYMR?
Deer Management Co. LLC has disclosed KYMR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Deer Management Co. LLC's current position in KYMR?
As of Q2 2026, Deer Management Co. LLC holds 125.89K shares of KYMR (KYMERA THERAPEUTICS INC), valued at $14.44M, representing 1.78% of its reported portfolio and ranking #6.
Has Deer Management Co. LLC been buying or selling KYMR?
In the latest 13F filing (Q2 2026), Deer Management Co. LLC held unchanged its position in KYMR. The position peaked in Q3 2024 at 415.89K shares.
Which other funds hold KYMR?
Other major institutional holders of KYMR include BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, T. Rowe Price Investment Management, Inc., among 58 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.